Detail
| LncRNA Name | GAS5 |
| Synonyms | GAS5, NCRNA00030, SNHG2, ENST00000456293.5, GAS5-007 |
| Region | GRCh38_1:173863900-173868882 Sequence |
| Ensembl | ENSG00000234741 |
| RefSeq | NR_002578 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | Microarray, qPCR etc. |
| Sample | bladder cancer tissues |
| Expression Pattern | down-regulated |
| Function Description | In the training set, uc004cox.4 was up-regulated and GAS5 was down-regulated in BC patients. Moreover, the expression of urinary uc004cox.5 was an independent predictor for the recurrence of NMIBC patients. |
| Pubmed ID | 29516641 |
| Year | 2018 |
| Title | Cell-free lncRNA expression signatures in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer. |
| External Links |
| Links for GAS5 | GenBank HGNC lncrnadb Noncode |
| Links for bladder cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.